Clinical features results therapy children paraspinal soft tissue sarcoma report Intergroup Rhabdomyosarcoma Study Soft tissue sarcomas paraspinal region patients eligible Intergroup Rhabdomyosarcoma IRS-I II IRS-II lesions cm diameter diagnosis spinal extradural space extraosseous Ewing sarcoma undifferentiated sarcoma subtype cases Patients tumors clinical groups II III IV radiotherapy XRT vincristine-dactinomycin VA VA cyclophosphamide VAC doxorubicin Clinical group patients IRS-II XRT IRS-I VAC XRT paraspinal patients complete response CR patients disease sites Twenty-seven patients local regional local distant distant proportion patients years clinical group stage IV Paraspinal patients survival patients disease sites IRS-I IRS-II percentage paraspinal patients years IRS-I IRS-II percentages patients disease sites Histology CR rate patients embryonal rhabdomyosarcoma RMS overall survival rate patients paraspinal lesions extended-field radiation therapy high local failure rate intensive chemotherapy local systemic tumor control 